Analyst Ratings for ZIOPHARM Oncology (ZIOP) [Neutrals]
ZIOP Rating Summary
ZIOP Price Target Summary
- Highest: $9.00 (Canaccord Genuity)
- Lowest: $1.00 (BMO Capital)
- Average: $5.50
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$5.50 (+212.5%)
Avg. $ Target:
$5.50 (+212.5%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/27/2013 | Brinson Patrick | Downgrade | Market Perform (Market Outperform) |
1.50 (7.00) |
1.82 | 1.76 | -3.3% | Details |
| 3/27/2013 | JPMorgan | Downgrade | Neutral (Overweight) |
N/A (N/A) |
1.82 | 1.76 | -3.3% | Details |
| 3/26/2013 | JMP Securities | Downgrade | Market Perform (Market Outperform) |
N/A (N/A) |
5.13 | 1.76 | -65.69% | Details |
| 1/18/2013 | Piper Jaffray | New Coverage | Neutral (N/A) |
5.00 (N/A) |
4.17 | 1.76 | -57.79% | Details |
| 12/12/2012 | Jefferies | Downgrade | Hold (Buy) |
4.00 (7.00) |
4.44 | 1.76 | -60.36% | Details |
